Growing demand for precision medicine and biomarkers will drive C-reactive protein testing market growth.Wilmington, Delaware, United States, Feb. 15, 2024 (GLOBE NEWSWIRE) Transparency Market Research Inc. - The C-reactive protein testing market was worth US$ 3.1 billion in 2022. A CAGR of 2.9% is projected from 2023 to 2031, and the market will reach more than US$ 4.0 billion in 2031. Integrating data from diverse sources, such as genetic information, electronic health records, and real-tim
/PRNewswire/ The last few years have witnessed increase in patient population suffering from respiratory diseases in countries in Europe and Middle East and.
Increase in the prevalence of Turners' syndrome and Down's syndrome among newborn babies drives the market growthSurge in the adoption of next-gen non-invasive DNA tests in high-risk pregnancies
/PRNewswire/ The global non-invasive prenatal testing market is prognosticated to reach a value of US$ 8.4 Bn by the end of 2031, notes an analysis by.